Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Wallstent copes well with diffuse vein grafts

This article was originally published in Clinica

Executive Summary

Initial experience indicates that Schneider's Wallstent is suitable for diffuse lesions in both native coronary arteries and venous bypass grafts without subsequent anticoagulation, indicate data from Dr Antonio Colombo's group in Milan, Italy. The group retrospectively analysed the outcome in 988 cases. Follow-up data at 5.4 months was available for 76% of the patients. Restenosis was 32.5% with 15% diffuse within the stent. Stent thrombosis was low but procedural complications were high when peripheral stents had been used. This was, however, offset by a greater gain in vessel diameter.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT087713

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel